169 related articles for article (PubMed ID: 12785792)
1. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers.
Griffin JH; Linsell MS; Nodwell MB; Chen Q; Pace JL; Quast KL; Krause KM; Farrington L; Wu TX; Higgins DL; Jenkins TE; Christensen BG; Judice JK
J Am Chem Soc; 2003 May; 125(21):6517-31. PubMed ID: 12785792
[TBL] [Abstract][Full Text] [Related]
2. Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria.
Hadjivassileva T; Thurston DE; Taylor PW
J Antimicrob Chemother; 2005 Sep; 56(3):513-8. PubMed ID: 16024592
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of the active conformation of vancomycin dimers with antibacterial activity against vancomycin-resistant bacteria.
Nakamura J; Yamashiro H; Hayashi S; Yamamoto M; Miura K; Xu S; Doi T; Maki H; Yoshida O; Arimoto H
Chemistry; 2012 Oct; 18(40):12681-9. PubMed ID: 22915313
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and antibacterial activity of demethylvancomycin analogues against drug-resistant bacteria.
Chang J; Zhang SJ; Jiang YW; Xu L; Yu JM; Zhou WJ; Sun X
ChemMedChem; 2013 Jun; 8(6):976-84. PubMed ID: 23576378
[TBL] [Abstract][Full Text] [Related]
5. Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci.
Xing B; Yu CW; Ho PL; Chow KH; Cheung T; Gu H; Cai Z; Xu B
J Med Chem; 2003 Nov; 46(23):4904-9. PubMed ID: 14584941
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria.
Lu J; Yoshida O; Hayashi S; Arimoto H
Chem Commun (Camb); 2007 Jan; (3):251-3. PubMed ID: 17299629
[TBL] [Abstract][Full Text] [Related]
7. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
8. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and their combinations with vancomycin.
Sato M; Tanaka H; Oh-Uchi T; Fukai T; Etoh H; Yamaguchi R
Phytother Res; 2004 Nov; 18(11):906-10. PubMed ID: 15597305
[TBL] [Abstract][Full Text] [Related]
10. Solid-phase synthesis and antibacterial evaluations of N-demethylvancomycin derivatives.
Yao NH; Liu G; He WY; Niu C; Carlson JR; Lam KS
Bioorg Med Chem Lett; 2005 May; 15(9):2325-9. PubMed ID: 15837318
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
Hu L; Kully ML; Boykin DW; Abood N
Bioorg Med Chem Lett; 2009 Jul; 19(13):3374-7. PubMed ID: 19481935
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Garrison MW; Nuemiller JJ
Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
Hossion AM; Otsuka N; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Zamami Y; Sasaki K
Bioorg Med Chem Lett; 2010 Sep; 20(17):5349-52. PubMed ID: 20655215
[TBL] [Abstract][Full Text] [Related]
16. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
18. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
Huang YT; Liao CH; Teng LJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
